Sterol regulatory element-binding factor 2 (SREBF-2) predicts 7-year NAFLD incidence and severity of liver disease and lipoprotein and glucose dysmetabolism
about
Gene polymorphisms associated with non-alcoholic fatty liver disease and coronary artery disease: a concise reviewA network biology workflow to study transcriptomics data of the diabetic liver.Translational approaches: from fatty liver to non-alcoholic steatohepatitis.Identification of genes whose expression is altered by obesity throughout the arterial tree.Systematic review of genetic association studies involving histologically confirmed non-alcoholic fatty liver disease.Hepatic notch signaling correlates with insulin resistance and nonalcoholic fatty liver disease.Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver diseaseHealth and economic benefits of reducing sugar intake in the USA, including effects via non-alcoholic fatty liver disease: a microsimulation model.The effects of ezetimibe on non-alcoholic fatty liver disease and glucose metabolism: a randomised controlled trial.Fatty liver without a large "belly": Magnified review of non-alcoholic fatty liver disease in non-obese patients.Non-alcoholic Fatty Liver Disease in Lean Subjects: Characteristics and Implications.Antibody-Directed Glucocorticoid Targeting to CD163 in M2-type Macrophages Attenuates Fructose-Induced Liver Inflammatory Changes.Non-high-density lipoprotein cholesterol independently predicts new onset of non-alcoholic fatty liver disease.TM6SF2 rs58542926 variant affects postprandial lipoprotein metabolism and glucose homeostasis in NAFLD.CAT-2003: A novel sterol regulatory element-binding protein inhibitor that reduces steatohepatitis, plasma lipids, and atherosclerosis in apolipoprotein E*3-Leiden mice.Anti-steatotic and anti-inflammatory roles of syringic acid in high-fat diet-induced obese mice.
P2860
Q26766459-180DADF0-8CA3-4C3B-8454-32CE9325F6E4Q30869985-8E3F976C-232B-4D69-8FF1-6B46FE49D8EDQ33958697-E35F6354-1F5A-4816-B172-B63327F0B6FAQ34519267-A7E6BF1C-2850-4D26-829A-A0E92F4268EEQ36140409-5219AE34-AED9-4000-B67A-17A0674AA920Q37333482-DBF16887-C40A-4A81-9E0A-EFAB0C5421E4Q37596189-2E8551C7-0F09-4858-AB88-1EAD3F614394Q38642356-6B9495C8-F313-4310-B244-3191DFB432FAQ39275836-CF27EA7C-3712-4677-8221-C7114338037CQ41449920-67549B73-1047-4BE2-8F2C-E040641AED90Q41706829-AEB848CF-DEDA-4B62-A0BE-7874445BC845Q42284206-566AFB00-ABB4-4BAB-8879-6A50324CF298Q45408801-22F1ED20-1298-435F-8B25-27BE28AB378DQ51271856-51C081F8-E5B5-4A49-A47A-E1705B10CA80Q51754950-78A6B357-E921-4141-83F9-D9A55853A4C6Q53799057-0B514E94-CCFD-4673-96C0-CC00D86A31E5
P2860
Sterol regulatory element-binding factor 2 (SREBF-2) predicts 7-year NAFLD incidence and severity of liver disease and lipoprotein and glucose dysmetabolism
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Sterol regulatory element-bind ...... tein and glucose dysmetabolism
@ast
Sterol regulatory element-bind ...... tein and glucose dysmetabolism
@en
type
label
Sterol regulatory element-bind ...... tein and glucose dysmetabolism
@ast
Sterol regulatory element-bind ...... tein and glucose dysmetabolism
@en
prefLabel
Sterol regulatory element-bind ...... tein and glucose dysmetabolism
@ast
Sterol regulatory element-bind ...... tein and glucose dysmetabolism
@en
P2093
P2860
P356
P1433
P1476
Sterol regulatory element-bind ...... tein and glucose dysmetabolism
@en
P2093
Franco De Michieli
Giovanni Musso
Maurizio Cassader
Roberto Gambino
P2860
P304
P356
10.2337/DB12-0858
P407
P577
2012-12-28T00:00:00Z